Webinar | Is your natural food dye compliant, shelf-stable, and ready to scale?
24th July | 12 PM ET: Register Now

Akrivia Biomedics

Akrivia Biomedics develops biology-driven molecular diagnostics to guide personalized cancer treatment and improve therapy decisions.
2019
11-50
London, England, United Kingdom
  • Drug Discovery and Development
  • Oncology (Cancer)
  • Pathology & Diagnostics
  • Personalized Medicine Technologies

Investment Funding

Revenue

$1M to $10M

Something missing or incorrect on this page? Help us enrich this information